Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study (2013)
Source: Abstracts. Conference titles: Annual Meeting of Association for Research in Vision and Ophthalmology (ARVO). Unidade: FMRP
Subjects: EDEMA MACULAR CISTOIDE, DOENÇAS RETINIANAS
ABNT
NEPOMUCENO, A. et al. Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study. 2013, Anais.. Seattle: ARVO, 2013. . Acesso em: 03 jun. 2024.APA
Nepomuceno, A., Almeida, F. P., Messias, A. M. V., Takaki, É., Ribeiro, J. A. S., Cardillo, J. A., et al. (2013). Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study. In Abstracts. Seattle: ARVO.NLM
Nepomuceno A, Almeida FP, Messias AMV, Takaki É, Ribeiro JAS, Cardillo JA, Scott IU, Jorge R. Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study. Abstracts. 2013 ;[citado 2024 jun. 03 ]Vancouver
Nepomuceno A, Almeida FP, Messias AMV, Takaki É, Ribeiro JAS, Cardillo JA, Scott IU, Jorge R. Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study. Abstracts. 2013 ;[citado 2024 jun. 03 ]